Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Fair Lawn, New Jersey 07410


Purpose:

The purpose of this 3 week study is to test the effectiveness of an over-the-counter (OTC) skin balm in infants and toddlers with mild to moderate dry, itchy skin.


Study summary:

50 infants and toddlers will be enrolled in this study to yield 40 completed subjects, 30 babies in the active treatment group and 10 babies in the positive control group. Infants and toddlers aged 6 to 47 months inclusive will receive either a prescription or non-marketed investigational product for the treatment of eczema. Caregivers will be asked to stop use of prescription eczema treatments one week before the start of the study and during the study. Caregivers will apply study product to babies as indicated for 14 days to affected areas. Subject caregivers will record treatment use in a daily diary and complete questionnaires. A dermatologist will examine and score the babies eczema and symptoms. Skin moisture levels will also be tested.


Criteria:

Inclusion Criteria: 1. Able to comprehend and follow the requirements of the study (including availability on scheduled visit dates) 2. Male or female of any race or ethnicity, 6 months to 47 months of age; 3. Diagnosed as having eczema 4. Willing to stop use of all non-assigned moisturizers and/or creams for the entire duration of the study 5. Child must have bedtime/sleep issues due to their dry, itchy skin Exclusion Criteria: 1. Use of a therapeutic (over-the-counter or prescription) body wash that contains an active ingredient for eczema 2. Participation in any clinical study within 30 days of Visit 1 3. Active infection of any type at the start of the study 4. Diagnosed as having severe eczema 5. Atopic Dermatitis requiring systemic, super-potent (Class I) or potent (Class II or III) topical corticosteroids 6. Child wakes up 3 or more times during the night 7. Child is awake more than 60 minutes during the night 8. Child sleeps for less than a total of 9 hours (during the day or night) 9. Child requires greater than 2.0 mg per day of inhaled or intranasal corticosteroids


NCT ID:

NCT02404493


Primary Contact:

Study Director
Amisha Parikh-Das, PhD
Johnson & Johnson Consumer Inc. (J&JCI)


Backup Contact:

N/A


Location Contact:

Fair Lawn, New Jersey 07410
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.